Molls M, Quast U, Schaefer U W, Szy D, Beelen D W, Quabeck K, Graeven U, Sayer H G, Bamberg M, Sack H
Department of Radiotherapy, West German Tumour Centre, University Hospital, Essen.
Radiother Oncol. 1990;18 Suppl 1:121-4. doi: 10.1016/0167-8140(90)90190-8.
Total body irradiation (TBI) prior to bone marrow transplantation (BMT) is applied for treatment of 230 patients in the period 1975-1988. The clinical results of 169 patients treated by four different TBI dosage and treatment techniques are analysed. The risk of leukemic relapse is low after fractionated TBI (9%) as well as after single dose TBI (14%). The lowest frequency of interstitial pneumonitis (21%) occurred when the patient translation technique was used for fractionated homogeneous pa/ap TBI with 10 Gy (8 Gy lung dose) in 4 fractions in 4 days. Prophylaxis of GVHD and the modus of protective environment were two other factors which influence the risk of IP.
1975年至1988年期间,230例患者在骨髓移植(BMT)前接受了全身照射(TBI)。分析了169例采用四种不同TBI剂量和治疗技术治疗的患者的临床结果。分次TBI(9%)和单次剂量TBI(14%)后白血病复发风险较低。当患者平移技术用于分次均匀pa/ap TBI,总剂量10 Gy(肺部剂量8 Gy),分4次在4天内给予时,间质性肺炎的发生率最低(21%)。移植物抗宿主病(GVHD)的预防和保护环境的方式是影响IP风险的另外两个因素。